Vertex Pharmaceuticals
VRTX
#155
Rank
NZ$249.60 B
Marketcap
NZ$984.49
Share price
-0.16%
Change (1 day)
29.76%
Change (1 year)

Earnings for Vertex Pharmaceuticals (VRTX)

Earnings in 2026 (TTM): NZ$7.97 Billion

According to Vertex Pharmaceuticals's latest financial reports the company's current earnings are NZ$12.95 Billion. In 2025 the company made an earning of NZ$8.67 Billion, an increase over its 2024 earnings that were of NZ$0.50 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vertex Pharmaceuticals from 1990 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$7.97 B-8.13%
2025 NZ$8.67 B1627.59%
2024 NZ$0.50 B-93.69%
2023 NZ$7.96 B3.19%
2022 NZ$7.71 B53.56%
2021 NZ$5.02 B-12.06%
2020 NZ$5.71 B118.45%
2019 NZ$2.61 B120.64%
2018 NZ$1.18 B1473.64%
2017 NZ$75.33 M197.6%
2016 NZ$25.31 M-102.97%
2015 -NZ$0.86 Billion-28.46%
2014 -NZ$1.2 Billion-51.5%
2013 -NZ$2.46 Billion-30584.68%
2012 NZ$8.05 M-95.47%
2011 NZ$0.17 B
2009 -NZ$1.07 Billion
2007 -NZ$0.75 Billion83.1%
2006 -NZ$0.41 Billion59.02%
2005 -NZ$0.26 Billion3.28%
2004 -NZ$0.25 Billion-38.16%
2003 -NZ$0.4 Billion
2000 -NZ$68.47 Million-20.38%
1999 -NZ$85.99 Million31.62%
1998 -NZ$65.33 Million91.05%
1997 -NZ$34.2 Million-36.24%
1996 -NZ$53.64 Million12.45%
1995 -NZ$47.7 Million27.4%
1994 -NZ$37.44 Million-1833.33%
1993 NZ$2.15 M-112.12%
1992 -NZ$17.82 Million175%
1991 -NZ$6.48 Million-12.2%
1990 -NZ$7.38 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$33.69 B 310.44%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$23.06 B 180.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-NZ$4.56 Billion-155.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.09 B 47.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$20.39 B 148.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
-NZ$90.38 Million-101.10%๐Ÿ‡บ๐Ÿ‡ธ USA